Two Chinese nationals arrested in the U.S. over GPU smuggling worth 'tens of millions of dollars' — over 20 shipments of AI chips and numerous illicit payments tracked
The U.S. Department of Justice has arrested two Chinese nationals on a federal criminal complaint that alleges they exported AI GPUs worth tens of millions of dollars to China in exchange for cash. Chuan Geng, 28, of Pasadena, and Shiwei Yang, 28, of El Monte, face up to 20 years in prison if found guilty, according to the DoJ.
As stated in the press release, the two alleged offenders have been charged with violating the Export Control Reform Act. From October 2022 to July 2025, it is alleged that they used a company, ALX Solutions Inc., to "knowingly and willfully" export sensitive technology, including GPUs, from the U.S. to China without a license or authorization.
It is alleged that the company was setup shortly after the Commerce Department started requiring such licenses for the very same goods Yang and Geng are said to have exported, implying it was done so explicitly for illicit purposes.
According to export records, a shipment in December 2024 and "at least 20 previous shipments" from the company "involved exports from the U.S. to shipping and freight-forwarding companies in Singapore and Malaysia," known transshipment points used to smuggle GPUs into China.
The charges state that ALX Solutions never received payments from the entities they were allegedly selling the goods too, but rather received "numerous payments" from companies in Hong Kong and China, including one worth $1 million in January 2024.
The December 2024 shipment was purportedly labeled, claiming it was sending GPUs subject to federal laws and regulations, when in reality it contained unlicensed GPUs.
The release does not specify which chips the perps were allegedly moving between the U.S. and China. However, the chip (singular, implying only one variant), was made "by a manufacturer of high-performance AI chips" and is quoted as being "the 'most powerful GPU chip on the market,'' and is 'designed specifically for AI applications,'" including developing self-driving cars, medical diagnosis systems, and other AI powered applications. Therefore, it seems highly plausible that the chip in question is likely the Nvidia H100 or B200.
Law enforcement have reportedly searched the offices of the offending shell company, seizing phones that include "incriminating communications" between defendants. After surrendering to authorities on August 2, Geng was released on a $250,000 bond. An August 12 detention hearing has been set for Yang, who remains in custody because they are in the U.S. illegally, having overstayed their visa.
Arraignment is scheduled for September 11.
Follow Tom's Hardware on Google News to get our up-to-date news, analysis, and reviews in your feeds. Make sure to click the Follow button.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Strattec Security Corp (STRT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Revenue Growth: 6% increase for the quarter and 5% for the fiscal year. Cash from Operations: $30 million for the quarter and $71 million for the fiscal year. Gross Margin Expansion: 370 basis points for the quarter and 280 basis points for the year. EBITDA Margin: 8.5% for the fourth quarter and 7.7% for the fiscal year. Gross Profit: Increased to $25.4 million for the fourth quarter. Operating Cash Flow: $30.2 million for the quarter, a 55% improvement over the same period last year. Free Cash Flow: $64.5 million for the fiscal year. Capital Expenditures: $7.2 million for the fiscal year. Cash Position: Ended the year with $84.6 million in cash. Available Credit Facilities: Approximately $52 million available. Warning! GuruFocus has detected 4 Warning Signs with CSAN. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Strattec Security Corp (NASDAQ:STRT) ended fiscal 2025 with strong sales growth and expanded margins. The company generated $30 million in cash from operations for the quarter and $71 million for the fiscal year. Revenue grew 6% in the quarter and 5% for the year, driven by strategic pricing initiatives and higher demand. Gross margin expanded by 370 basis points for the quarter and 280 basis points for the year. The company has a healthy cash position of $84.6 million and approximately $52 million available under revolving credit facilities. Negative Points The company faces ongoing tariff expenses, with an estimated annual cost increase between $5 million to $7 million. Higher labor costs in Mexico are impacting the company's financials. The fiscal year 2026 is expected to see lower North American automotive production, potentially affecting sales. The company is still in the early stages of its transformation process, with long-term changes needed. There is uncertainty in the market, which may impact the company's ability to maintain its current cash flow levels. Q & A Highlights Q: How far along is Strattec in its transformation process, and what does the future look like for this initiative? A: Jennifer Slater, President and CEO, stated that Strattec is still in the early stages of its transformation. While they have addressed much of the low-hanging fruit in fiscal year 2025, future transformation efforts will be more long-term in nature. Q: Is Strattec considering exiting or divesting any product lines as part of its transformation? A: Jennifer Slater mentioned that Strattec is refocusing its engineering efforts on products with more growth potential, such as power access products and digital key fobs, rather than crowded markets like the switch product line. Q: What is the outlook for Strattec's gross margins in fiscal 2026? A: Matthew Pauli, CFO, indicated that while fiscal 2025 ended with a 15% gross margin, fiscal 2026 is expected to see revenues down to flattish. However, they anticipate tailwinds from pricing actions and restructuring efforts, balanced by inflationary pressures and volume headwinds. Q: How does Strattec plan to utilize its substantial cash reserves, and what is considered an appropriate cash cushion? A: Jennifer Slater explained that the company is comfortable with its current cash position, which provides stability amid market uncertainties. They are focusing on transforming the business and will consider cash allocation for shareholder value once there is more market certainty. Q: What are Strattec's plans for new product offerings or revenue opportunities in the next three to five years? A: Jennifer Slater stated that Strattec is focusing on expanding its customer base within its current product portfolio, particularly in power access and digital key products, while also exploring opportunities with new customers. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
16 minutes ago
- Yahoo
BioLargo Inc (BLGO) Q2 2025 Earnings Call Highlights: Strategic Moves Amid Revenue Challenges
Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BioLargo Inc (BLGO) has maintained its net stockholders' equity at around $6 million despite recent losses, showcasing effective capital management. The company has seen a significant increase in service revenues, rising from $300,000 to $1.2 million in the first half of the year. BioLargo Inc (BLGO) has successfully shipped its AEC unit to New Jersey, with validation work to be conducted by state and federal EPA, enhancing credibility. The company has raised $3.3 million in its subsidiary, Clyra Medical, indicating strong investor confidence in its potential. BioLargo Inc (BLGO) is pursuing a capital-conserving strategy by forming joint ventures for battery manufacturing, leveraging public funding and partnerships. Negative Points BioLargo Inc (BLGO) experienced a decline in revenue, with $3 million in the recent quarter compared to $5 million in the same period last year. The company faces uncertainty with its partner Ikigai and Pooph, impacting cash flow and financial forecasting. There is a significant delay in the commercialization of Clyra's wound care product, raising concerns about execution timelines. BioLargo Inc (BLGO) has increased debt obligations, primarily related to Clyra's preparation for product launch. The company is operating under financial pressure due to reduced cash flow from Pooph sales, necessitating cautious financial management. Q & A Highlights Warning! GuruFocus has detected 7 Warning Signs with BLGO. Q: Can you provide any additional insight into the challenges and successes to the barriers to entry for the salinity battery? A: Dennis Calvert, CEO, explained that the primary challenges include technical proof of claim, scaling up manufacturing, and regulatory hurdles. The company has achieved significant technical milestones and is working on scaling up production. Regulatory barriers are relatively low, focusing mainly on safety data and UL certification. The company is confident in its technology and is working towards proving its claims and securing partnerships. Q: Will BioLargo be funding the cost to build battery factories? Will you be involved in designing and building the factories? A: Dennis Calvert, CEO, stated that BioLargo will not be funding the factories directly. Instead, they will act as a vendor, providing engineering services, project management, and technology transfer. The factories will be financed through partnerships, public funding, and other financial arrangements, allowing BioLargo to focus on leveraging its core competencies. Q: What is the latest on New Jersey and the AEC project? A: Dennis Calvert, CEO, reported that the AEC unit has been shipped and is being set up in Lake Stockholm. The state and federal EPA will participate in validation work, which is crucial for future customer demonstrations. The company is excited about this significant milestone and will announce the go-live date soon. Q: How can you be so confident about Clyra given that it's taken so long? A: Dennis Calvert, CEO, expressed confidence in Clyra due to recent investments of $3.3 million and the technical prowess of their invention. The company is preparing for a significant product launch with strong partnerships in place. They aim to complete third-party testing and FDA paperwork by the end of the year, targeting a Q1 launch. Q: Do you have insight on Pooph's operations as far as advertising spend, the number of stores that they're in? A: Dennis Calvert, CEO, mentioned limited insight into Pooph's operations, making it difficult to forecast. However, he noted that Pooph had previously achieved a $50 million run rate and was in 40,000 stores. The company remains optimistic about Pooph's potential but is cautious due to uncertainties. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
16 minutes ago
- Yahoo
Flowers Foods Inc (FLO) Q2 2025 Earnings Call Highlights: Navigating Market Shifts with ...
Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Flowers Foods Inc (NYSE:FLO) is aggressively transitioning its portfolio to align with current consumer demand, which is expected to drive long-term growth. The company has seen success with its differentiated products, such as Dave's Killer Bread and Canyon Bakehouse, which are performing well in the market. Flowers Foods Inc (NYSE:FLO) is actively innovating, with new products like small loaves and keto offerings showing promising growth. The company is experiencing substantial space gains in mass channels for its organic products, particularly Dave's Killer Bread, indicating strong market acceptance. Despite challenges, Flowers Foods Inc (NYSE:FLO) maintains a strong market share performance, particularly in premium and differentiated product segments. Negative Points The company is facing increased competitive pressure, particularly from new lower-priced bread products affecting traditional loaf sales. There is ongoing weakness in the away-from-home food service business, impacting overall performance. Flowers Foods Inc (NYSE:FLO) has reduced its EPS guidance, narrowing the gap between dividend commitments and current EPS run rate. The transition to align with shifting consumer trends is expected to take time, requiring patience from stakeholders. The company is experiencing negative fixed cost leverage due to lower volumes, impacting gross margins. Q & A Highlights Warning! GuruFocus has detected 6 Warning Sign with FLO. Q: Ryals, can you provide more details on the competitive environment and the impact of new lower-priced bread products? A: The promotional environment is elevated but stable. We've increased promotions, especially for differentiated products like Dave's Killer Bread (DKB), which performed well. Lower-priced entrants are affecting traditional loaf areas, but we're addressing this with our own small loaves. The market remains bifurcated, with good performance in premium and value segments, particularly in mass and club channels. We're also seeing continued weakness in the away-from-home food service business. Q: Steve, regarding the updated tariff outlook, have previous tariff costs been delayed or structurally updated? Also, how does the reduction in EPS guidance affect capital allocation, especially concerning dividends? A: The tariff update is structural, with expectations for tariffs to decrease based on current observations. Regarding capital allocation, we maintain a balanced approach, and the board evaluates performance, cash flow, and liquidity quarterly. We don't have a stated target payout ratio, but on a cash basis, it's different due to depreciation and amortization being above CapEx. Q: Are we returning to a highly competitive environment similar to years ago, with aggressive pricing strategies? A: The category is transitioning due to shifting consumer trends, such as health and wellness and ultra-processed food concerns. We're committed to innovation to navigate this transition. Traditional loaf products are most affected, but we're seeing success with differentiated products like DKB and Canyon Bakehouse. We have plans to address traditional loaf weaknesses, but I won't disclose details for competitive reasons. Q: Can you comment on the performance of Wonder and its impact on Tastykake? A: Wonder's launch has exceeded expectations without cannibalizing Tastykake, likely due to geographic strengths. Wonder is a national brand, while Tastykake is strong in the mid-Atlantic. We're pleased with Wonder's performance and have more innovation planned. Q: How long will the transition take, and are there near-term solutions to speed it up? A: The transition will take time, but I won't specify a duration. The category will stabilize eventually, driven by consumer behavior shifts and the pandemic's final effects. Our focus is on innovation to replace declines in traditional loaf sales. We have the number one brand and SKU, and we'll continue investing in brands like Nature Zone to mitigate losses. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
